Events

https://www.pharmacytimes.com

Upcoming
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma
March 4, 2025
5:30 pm
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma
Upcoming
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma
March 19, 2025
5:30 pm
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma
Upcoming
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma
March 27, 2025
5:30 pm
Precision Oncology: Leveraging PD-L1 Inhibitors for Metastatic Esophageal Squamous Cell Carcinoma